Quantcast
Last updated on April 24, 2014 at 6:16 EDT

Lupin Launches Generic Aciphex® Delayed-Release Tablets, 20 mg in the US

November 11, 2013

MUMBAI and BALTIMORE, November 11, 2013 /PRNewswire/ –

Pharma Major Lupin Limited (Lupin) announced today that its US subsidiary, Lupin
Pharmaceuticals, Inc. (LPI) has launched its generic Rabeprazole Sodium delayed-release
tablets, 20mg. Lupin had earlier received final approval from the US FDA for the same.

Lupin’s Rabeprazole Sodium delayed-release tablets, 20mg, are the generic equivalent
of Eisai Inc.’s Aciphex(R) delayed-release tablets, 20mg, and are indicated for the
treatment of Gastroesophageal reflux disease (GERD). Aciphex(R) delayed-release tablets,
20mg, had annual U.S sales of approximately US$ 864.3 million (IMS MAT Jun 2013).

About Lupin Limited

Lupin is an innovation led transnational pharmaceutical company producing and
developing a wide range of branded and generic formulations and APIs globally. The Company
is a significant player in the Cardiovascular, Diabetology, Asthma, Pediatric, CNS, GI,
Anti-Infective and NSAID space and holds global leadership positions in the Anti-TB and
Cephalosporin segment.

Lupin is the 5th largest and fastest growing top 5 generics player in the US (5.3%
market share by prescriptions, IMS Health) and the 3rd largest Indian pharmaceutical
company by sales. The Company is also the fastest growing top 10 generic pharmaceutical
players in Japan and South Africa (IMS).

For the financial year ended March 2013, Lupin’s Consolidated turnover and Profit
after Tax were Rs. 94,616 million (USD 1.74 billion) and Rs. 13,142 million (USD 242
million) respectively. Please visit http://www.lupinworld.com for more information.

Headquartered in Baltimore, Maryland, Lupin Pharmaceuticals, Inc. is dedicated to
delivering high-quality, affordable generic medicines and branded formulations trusted by
healthcare professionals and patients across geographies. For more information, visit

http://www.lupinpharmaceuticals.com

For more information, please contact -

        Shamsher Gorawara
        Head - Corporate Communications
        Ph: +91-98-20-338-555
        Email: shamshergorawara@lupinworld.com

        Safe Harbor Statement [http://www.lupinworld.com/safe harbor ]
        * ACIPHEX(R) is a registered trademark used by Eisai Inc.

SOURCE Lupin Ltd


Source: PR Newswire